Simultaneous analytical method [Bioanalytics]

posted by Obinoscopy  – USA, 2018-09-12 09:35 (903 d 01:58 ago) – Posting: # 19268
Views: 2,566

Dear Giang

» It's a bioanalytical method for determination of 5 anti-TB drugs by LC-MS/MS. One just raise the question: Can we apply this method for just 2/3 APIs? Is there any infuence or differences? Do we need to revalidate the method, partial or full, and which criteria? Many thanks!

I don't think you need to revalidate as long as the 2/3 APIs were among the 5 APIs that were validated.

But if I may ask, did you include all the CCs and QCs for the entire 5 APIs in the same analytical run?

Scopy

Complete thread:

Activity
 Admin contact
21,360 posts in 4,461 threads, 1,492 registered users;
online 9 (1 registered, 8 guests [including 4 identified bots]).
Forum time: Wednesday 10:34 CET (Europe/Vienna)

The art and science of asking questions
is the source of all knowledge.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5